These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 3327639

  • 1. Long-term prognosis of diffuse lupus nephritis.
    Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S.
    Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
    [Abstract] [Full Text] [Related]

  • 2. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 4. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 6. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB.
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [Abstract] [Full Text] [Related]

  • 7. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 8. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G, Oner A, Erdoğan O, Delibaş A, Baysun S, Bülbül M, Bek K, Oksal A.
    Ren Fail; 2008 Jul; 30(6):603-9. PubMed ID: 18661410
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 10. Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod.
    Hariharan S, Pollak VE, Kant KS, Weiss MA, Wadhwa NK.
    Clin Nephrol; 1990 Aug; 34(2):61-9. PubMed ID: 2225555
    [Abstract] [Full Text] [Related]

  • 11. Lupus nephritis: a 13-year experience.
    Walker RJ, Bailey RR, Swainson CP, Lynn KL.
    N Z Med J; 1986 Nov 26; 99(814):894-6. PubMed ID: 3468414
    [Abstract] [Full Text] [Related]

  • 12. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep 26; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr 26; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 26; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 15. Lupus nephritis in children--a review of 167 patients.
    Yang LY, Chen WP, Lin CY.
    Pediatrics; 1994 Sep 26; 94(3):335-40. PubMed ID: 8065859
    [Abstract] [Full Text] [Related]

  • 16. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM.
    J Rheumatol; 1994 Nov 26; 21(11):2052-7. PubMed ID: 7869309
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A, Hotta O, Yusa N, Taguma Y.
    Ren Fail; 2007 Nov 26; 29(1):41-7. PubMed ID: 17365909
    [Abstract] [Full Text] [Related]

  • 18. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug 26; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 19. Longterm followup of childhood lupus nephritis.
    Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E.
    J Rheumatol; 2002 Dec 26; 29(12):2635-42. PubMed ID: 12465165
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov 26; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.